Treatment for Major Depressive Disorder with Psychotic Features

First-Line Pharmacological Treatment

The American Geriatrics Society recommends the combination of an antidepressant (preferably an SSRI) and an antipsychotic medication for the treatment of MDD with psychotic features, as this combination is significantly more effective than either medication class alone for acute treatment 1
The combination of an SSRI (such as sertraline, escitalopram, or fluoxetine) and a second-generation antipsychotic is the standard approach for treating MDD with psychotic features 1

The American College of Physicians suggests that Electroconvulsive therapy (ECT) is equally effective as combination pharmacotherapy and should be considered for patients requiring rapid improvement, those who fail to respond to medication combinations, and severe cases with high suicide risk 2

The American Geriatrics Society recommends using therapeutic doses of antidepressants equivalent to those used for non-psychotic depression 1

The American Academy of Child and Adolescent Psychiatry recommends adding Cognitive Behavioral Therapy (CBT) to the medication combination, particularly for adolescents and when feasible in adults, to address both depressive symptoms and psychotic features 3

The American Geriatrics Society recommends continuing full-dose combination therapy for at least 6 months after significant improvement for first or second episodes of major depression with psychotic features 1

The American Psychiatric Association suggests using standardized assessment tools (such as PHQ-9 or Hamilton Depression Rating Scale) at each visit to monitor both depressive severity and psychotic symptom response, with response defined as ≥50% reduction in measured severity 3, 4

The American Academy of Child and Adolescent Psychiatry recommends olanzapine plus fluoxetine as a validated combination approach for bipolar depression in adults, which can be applied to major depressive disorder with psychotic features 5
The FDA approves the combination of olanzapine and fluoxetine for bipolar depression in adults, indicating its potential efficacy for psychotic depression 5

Risperidone is approved for acute mania in adults, suggesting its efficacy in mood disorders with psychotic features, according to the American Academy of Child and Adolescent Psychiatry 5
Quetiapine is approved for acute mania in adults, indicating its potential use in combination with antidepressants for major depressive disorder with psychotic features, as recommended by the American Academy of Child and Adolescent Psychiatry 5